Your session is about to expire
← Back to Search
DSP-7888 Dosing Emulsion for Glioblastoma
Study Summary
This trial is testing a new cancer treatment against the current best treatment for people with a certain type of brain tumor.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 3 trial • 221 Patients • NCT03149003Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there other places in town where this trial is taking place?
"This study is enrolling patients at 40 sites across North America. If you choose to participate in the trial, it is important to select a site that is geographically close to reduce travel burden."
How many people are participating in this clinical trial at most?
"As of right now, this clinical trial is not looking for new patients. This study was first posted on December 8th, 2017 and updated as recently as April 4th, 2022. There are 458 other trials concerning glioblastoma currently enrolling participants and 376 studies involving DSP-7888 Dosing Emulsion that are actively recruiting patients."
Could you explain the general purpose of DSP-7888 Dosing Emulsion?
"DSP-7888 Dosing Emulsion is most commonly used as an intervention for malignant neoplasms. It can also be prescribed to treat various conditions including recurrent platinum sensitive primary peritoneal cancer, stage iv epithelial ovarian cancer following initial surgical resection, locally advanced nonsquamous non-small cell lung cancer."
What is the maximum recommended dosage for DSP-7888 Dosing Emulsion?
"There is some evidence of efficacy and multiple rounds of safety data, so our team at Power gives DSP-7888 a score of 3."
Are there similar trials to DSP-7888 Dosing Emulsion?
"Currently, there are 376 active clinical trials looking into DSP-7888 Dosing Emulsion. Out of these, 99 have progressed to Phase 3 testing. The majority of research is taking place in Taibei, Taiwan; however, there are a total of 18909 locations running studies related to DSP-7888 Dosing Emulsion."
Are there any open slots for new participants in this clinical trial?
"Unfortunately, this particular trial is not currently enrolling patients. Although, there are 458 trials for glioblastoma and 376 DSP-7888 Dosing Emulsion studies that are still seeking participants."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger